Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture Combined With Mirabegron for Overactive Bladder
NCT06181019Phase 1Active, not recruiting
- Sponsor
- Affiliated Ganzhou Hospital of Nanchang University
- Start
- Dec 2021
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by Affiliated Ganzhou Hospital of Nanchang University. Primary endpoints: Overactive Bladder Syndrome Score at 12 weeks and Voiding Diary Indicators at 12 weeks. Started Dec 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06181019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06181019.